bibliographic resource 1535566 [br/1535566]
https://w3id.org/oc/corpus/br/1535566

is a
title
  • Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations
publication date
  • 2015-01-01
contributor
identifier
part of